2L6E

NMR Structure of the monomeric mutant C-terminal domain of HIV-1 Capsid in complex with stapled peptide Inhibitor

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
2	2D 1H-13C HSQC	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
3	3D HNCO	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
4	3D HNCA	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
5	3D HN(CO)CA	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
6	3D HNCACB	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
7	3D CBCA(CO)NH	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
8	3D 1H-15N NOESY	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
9	3D 1H-13C NOESY	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	100% D2O	100	7.0	ambient	298
10	2D f1,f2 filtered 1H-1H NOESY	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
11	2D f2 filtered 1H-1H NOESY	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
12	3D H(CCO)NH	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298
13	3D HCCH-TOCSY	600 uM [U-100% 13C; U-100% 15N] Capsid protein p24, 900 uM NYAD-13 Peptide Inhibitor, 2 mM DTT, 100 mM ammonium acetate	90% H2O/10% D2O	100	7.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
simulated annealing	water refinement	CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	refinement	ARIA	2.2	Linge, O'Donoghue and Nilges
3	chemical shift assignment	CARA	1.5	Keller, Wuthrich
4	peak picking	CARA	1.5	Keller, Wuthrich
5	processing	TopSpin	1.3	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.